Comparative effectiveness is gaining momentum as a way to decide what drugs and devices should be used by doctors. But why was it part of the economic stimulus approved by Congress and pushed by President Obama? Dr. Les Paul, vice president of clinical and scientific affairs at the National Pharmaceutical Council, tells the Chicago Tribune's Bruce Japsen about how policymakers are looking at comparative effectiveness and how medical care providers and the healthcare industry should be involved.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Comparative Effectiveness and the Economic Stimulus Package
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Comparative effectiveness is gaining momentum as a way to decide what drugs and devices should be used by doctors. But why was it part of the economic stimulus approved by Congress and pushed by President Obama? Dr. Les Paul, vice president of clinical and scientific affairs at the National Pharmaceutical Council, tells the Chicago Tribune's Bruce Japsen about how policymakers are looking at comparative effectiveness and how medical care providers and the healthcare industry should be involved.
Presenters
Facebook Comments